期刊文献+

顺序特异性引物聚合酶链反应技术对HLA-DR DNA的分型 被引量:2

Typing for HLA-DR DNA by polymer- ase chain reaction with sequence-specif- ic primers
原文传递
导出
摘要 目的:应用顺序特异性引物聚合酶链反应技术(PCR-SSP)进行临床肾移植供受者HLA-DR位点DNA的分型。方法:设计并合成HLA-DR位点16对特异性引物和1对阳性对照引物,建立PCR-SSP法,对52份临床肾移植供受者的外周血淋巴细胞样本进行DR位点基因的分型。结果与微量PCR-SSP基因分型试剂盒分型方法比较。结果:所有临床样本的PCR-SSP基因分型均获得成功,结果与微量PCR-SSP基因分型试剂盒分型方法完全相同,分型时间3 h,特异性和重复性100%。结论:应用合成引物为临床肾移植供受者进行HLA-DR位点PCR-SSP基因分型简便快捷,重复性好,适合于临床应用。 AIM: To type the HLA-DR DNA for renal transplantation by PCR with sequence-specific primers (PCR-SSP). METHODS: According to nucleotide sequences of HLA-DR, 16 pairs of specific primers and a pair of positive control primers were designed and synthesized for PCR-SSP. Then HLA-DR sites of 52 donors and recipients for renal transplantation were typed by the PCR-SSP. RESULTS: All the samples were successfully typed by PCR-SSP with the synthesized primers. The results were available within 3 hours after sampling and the accuracy and reproducibility were 100%. CONCLUSION: Genotyping for HLA-DR sites by PCR-SSP with primers reported herein was a simple and accurate technique suitable for clinical application.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2003年第6期560-562,共3页 Chinese Journal of Cellular and Molecular Immunology
关键词 人白细胞抗原 聚合酶链反应 移植 HLA PCR transplantation kidney
  • 相关文献

参考文献3

二级参考文献2

  • 1谭建明,国外医学泌尿系统分册,1995年,15卷,23页
  • 2谭建明,国外医学泌尿系统分册,1994年,14卷,211页

共引文献25

同被引文献17

  • 1刘和,陈英旭,张文波,金勇丰.PCR一步法构建融合蛋白基因fpg[J].遗传,2004,26(4):525-528. 被引量:9
  • 2杨致荣,毛雪,李润植.植物次生代谢基因工程研究进展[J].植物生理与分子生物学学报,2005,31(1):11-18. 被引量:33
  • 3罗师平,冷希岗.基于PCR的体外诱变技术[J].国外医学(生物医学工程分册),2005,28(3):188-192. 被引量:25
  • 4王力华,付士红,唐青,杨益良,梁国栋.三重融合PCR法构建感染性辛德毕斯嵌合病毒cDNA克隆[J].病毒学报,2006,22(2):107-113. 被引量:8
  • 5Yon J,Fried M.Precise gene fusion by PCR.Nucleic Acids Res,2000,17:4895.
  • 6Sedivy JM,Dutriaux A.Gene targeting and somatic cell genetic S-rebirth or a coming of age.Trends Genet,1999,15:88-90.
  • 7Kuwayama H,Obara S,Morio T,et al.PCR-mediated generation of a gene disruption construct without the use of DNA ligase and plasmid vector.Nucleic Acid Res,2002,30(2):2.
  • 8Charlier N,Molenkamp R,Leyssen P,et al.A rapid and convenient variant of fusion-PCR to construct chimeric flaviviruses.Virol Metheds,2003,108(1):67-74.
  • 9Pharmd BG, Spencer MD, Maly RN, et al. Valproate-mediated disturbancesof hemostasis: relationship to dose and plasma concentration[J].Neurology, 1994, 44(4): 1418-1422.
  • 10Ward MM, Barbaro NM, Laxer KD, et al. Preoperative valproateadministration dose not increase blood loss during temporal lobectomy[J].Epilepsia, 1996, 37(3): 98-102.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部